ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Bipolar Disorder Drugs and Treatment Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-23S10367
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Bipolar Disorder Drugs and Treatment Market Research Report 2022
BUY CHAPTERS

Global Bipolar Disorder Drugs and Treatment Market Research Report 2025

Code: QYRE-Auto-23S10367
Report
February 2025
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
AbbVie
Glaxo SmithKline (GSK)
Eli Lily And Company
Janssen Pharmaceuticals
Johnson & Johnson
Astellas Pharma Inc
Bristol–Myers Squibb
Gedeon Richter Plc
H Lundbeck A S
Pfizer Inc
Novartis
Otsuka Holdings Co Ltd
Validus Pharmaceuticals LLC

Bipolar Disorder Drugs and Treatment Market Size

The global market for Bipolar Disorder Drugs and Treatment was valued at US$ 144 million in the year 2024 and is projected to reach a revised size of US$ 178 million by 2031, growing at a CAGR of 3.1% during the forecast period.

Bipolar Disorder Drugs and Treatment Market

Bipolar Disorder Drugs and Treatment Market

Drug therapy is currently the core method of treating bipolar disorder, that is, the use of emotional stabilizers to adjust the patient"s mood. Bipolar disorder is complex and difficult to control. The drug effect of emotional stabilizers can help patients to suppress their emotions when they are too high, to increase their emotions when they are depressed, to stabilize their emotions at a normal level, and to effectively prevent the recurrence of bipolar disorder. The quickest and most effective approach may be convulsive-free electroconvulsive therapy.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Bipolar Disorder Drugs and Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bipolar Disorder Drugs and Treatment.
The Bipolar Disorder Drugs and Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bipolar Disorder Drugs and Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bipolar Disorder Drugs and Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Bipolar Disorder Drugs and Treatment Market Report

Report Metric Details
Report Name Bipolar Disorder Drugs and Treatment Market
Accounted market size in year US$ 144 million
Forecasted market size in 2031 US$ 178 million
CAGR 3.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospital
  • Clinic
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AbbVie Inc., Glaxo SmithKline (GSK), Eli Lily and Company, Janssen Pharmaceuticals, Johnson & Johnson, Astellas Pharma Inc, Bristol Myers Squibb, Gedeon Richter PLC., H. Lundbeck A/S, Pfizer Inc., Novartis AG, Otsuka Holdings Co. Ltd, Validus Pharmaceuticals LLC.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Bipolar Disorder Drugs and Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Bipolar Disorder Drugs and Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Bipolar Disorder Drugs and Treatment Market growing?

Ans: The Bipolar Disorder Drugs and Treatment Market witnessing a CAGR of 3.1% during the forecast period 2025-2031.

What is the Bipolar Disorder Drugs and Treatment Market size in 2031?

Ans: The Bipolar Disorder Drugs and Treatment Market size in 2031 will be US$ 178 million.

Who are the main players in the Bipolar Disorder Drugs and Treatment Market report?

Ans: The main players in the Bipolar Disorder Drugs and Treatment Market are AbbVie Inc., Glaxo SmithKline (GSK), Eli Lily and Company, Janssen Pharmaceuticals, Johnson & Johnson, Astellas Pharma Inc, Bristol Myers Squibb, Gedeon Richter PLC., H. Lundbeck A/S, Pfizer Inc., Novartis AG, Otsuka Holdings Co. Ltd, Validus Pharmaceuticals LLC.

What are the Application segmentation covered in the Bipolar Disorder Drugs and Treatment Market report?

Ans: The Applications covered in the Bipolar Disorder Drugs and Treatment Market report are Hospital, Clinic

What are the Type segmentation covered in the Bipolar Disorder Drugs and Treatment Market report?

Ans: The Types covered in the Bipolar Disorder Drugs and Treatment Market report are Mood Stabilizers, Anticonvulsants, Antipsychotic Drugs, Antidepressant Drugs, Anti-Anxiety Drugs

Recommended Reports

Mental Health Drugs

Neurological Treatments

Drug Stability & Storage

1 Bipolar Disorder Drugs and Treatment Market Overview
1.1 Product Definition
1.2 Bipolar Disorder Drugs and Treatment by Type
1.2.1 Global Bipolar Disorder Drugs and Treatment Market Value Comparison by Type (2024 VS 2031)
1.2.2 Mood Stabilizers
1.2.3 Anticonvulsants
1.2.4 Antipsychotic Drugs
1.2.5 Antidepressant Drugs
1.2.6 Anti-Anxiety Drugs
1.3 Bipolar Disorder Drugs and Treatment by Application
1.3.1 Global Bipolar Disorder Drugs and Treatment Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Bipolar Disorder Drugs and Treatment Market Size Estimates and Forecasts
1.4.1 Global Bipolar Disorder Drugs and Treatment Revenue 2020-2031
1.4.2 Global Bipolar Disorder Drugs and Treatment Sales 2020-2031
1.4.3 Global Bipolar Disorder Drugs and Treatment Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Bipolar Disorder Drugs and Treatment Market Competition by Manufacturers
2.1 Global Bipolar Disorder Drugs and Treatment Sales Market Share by Manufacturers (2020-2025)
2.2 Global Bipolar Disorder Drugs and Treatment Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Bipolar Disorder Drugs and Treatment Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Bipolar Disorder Drugs and Treatment, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Bipolar Disorder Drugs and Treatment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bipolar Disorder Drugs and Treatment, Product Type & Application
2.7 Global Key Manufacturers of Bipolar Disorder Drugs and Treatment, Date of Enter into This Industry
2.8 Global Bipolar Disorder Drugs and Treatment Market Competitive Situation and Trends
2.8.1 Global Bipolar Disorder Drugs and Treatment Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Bipolar Disorder Drugs and Treatment Players Market Share by Revenue
2.8.3 Global Bipolar Disorder Drugs and Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Bipolar Disorder Drugs and Treatment Market Scenario by Region
3.1 Global Bipolar Disorder Drugs and Treatment Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Bipolar Disorder Drugs and Treatment Sales by Region: 2020-2031
3.2.1 Global Bipolar Disorder Drugs and Treatment Sales by Region: 2020-2025
3.2.2 Global Bipolar Disorder Drugs and Treatment Sales by Region: 2026-2031
3.3 Global Bipolar Disorder Drugs and Treatment Revenue by Region: 2020-2031
3.3.1 Global Bipolar Disorder Drugs and Treatment Revenue by Region: 2020-2025
3.3.2 Global Bipolar Disorder Drugs and Treatment Revenue by Region: 2026-2031
3.4 North America Bipolar Disorder Drugs and Treatment Market Facts & Figures by Country
3.4.1 North America Bipolar Disorder Drugs and Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Bipolar Disorder Drugs and Treatment Sales by Country (2020-2031)
3.4.3 North America Bipolar Disorder Drugs and Treatment Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Bipolar Disorder Drugs and Treatment Market Facts & Figures by Country
3.5.1 Europe Bipolar Disorder Drugs and Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Bipolar Disorder Drugs and Treatment Sales by Country (2020-2031)
3.5.3 Europe Bipolar Disorder Drugs and Treatment Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bipolar Disorder Drugs and Treatment Market Facts & Figures by Region
3.6.1 Asia Pacific Bipolar Disorder Drugs and Treatment Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Bipolar Disorder Drugs and Treatment Sales by Region (2020-2031)
3.6.3 Asia Pacific Bipolar Disorder Drugs and Treatment Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Bipolar Disorder Drugs and Treatment Market Facts & Figures by Country
3.7.1 Latin America Bipolar Disorder Drugs and Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Bipolar Disorder Drugs and Treatment Sales by Country (2020-2031)
3.7.3 Latin America Bipolar Disorder Drugs and Treatment Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Bipolar Disorder Drugs and Treatment Market Facts & Figures by Country
3.8.1 Middle East and Africa Bipolar Disorder Drugs and Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Bipolar Disorder Drugs and Treatment Sales by Country (2020-2031)
3.8.3 Middle East and Africa Bipolar Disorder Drugs and Treatment Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Bipolar Disorder Drugs and Treatment Sales by Type (2020-2031)
4.1.1 Global Bipolar Disorder Drugs and Treatment Sales by Type (2020-2025)
4.1.2 Global Bipolar Disorder Drugs and Treatment Sales by Type (2026-2031)
4.1.3 Global Bipolar Disorder Drugs and Treatment Sales Market Share by Type (2020-2031)
4.2 Global Bipolar Disorder Drugs and Treatment Revenue by Type (2020-2031)
4.2.1 Global Bipolar Disorder Drugs and Treatment Revenue by Type (2020-2025)
4.2.2 Global Bipolar Disorder Drugs and Treatment Revenue by Type (2026-2031)
4.2.3 Global Bipolar Disorder Drugs and Treatment Revenue Market Share by Type (2020-2031)
4.3 Global Bipolar Disorder Drugs and Treatment Price by Type (2020-2031)
5 Segment by Application
5.1 Global Bipolar Disorder Drugs and Treatment Sales by Application (2020-2031)
5.1.1 Global Bipolar Disorder Drugs and Treatment Sales by Application (2020-2025)
5.1.2 Global Bipolar Disorder Drugs and Treatment Sales by Application (2026-2031)
5.1.3 Global Bipolar Disorder Drugs and Treatment Sales Market Share by Application (2020-2031)
5.2 Global Bipolar Disorder Drugs and Treatment Revenue by Application (2020-2031)
5.2.1 Global Bipolar Disorder Drugs and Treatment Revenue by Application (2020-2025)
5.2.2 Global Bipolar Disorder Drugs and Treatment Revenue by Application (2026-2031)
5.2.3 Global Bipolar Disorder Drugs and Treatment Revenue Market Share by Application (2020-2031)
5.3 Global Bipolar Disorder Drugs and Treatment Price by Application (2020-2031)
6 Key Companies Profiled
6.1 AbbVie Inc.
6.1.1 AbbVie Inc. Company Information
6.1.2 AbbVie Inc. Description and Business Overview
6.1.3 AbbVie Inc. Bipolar Disorder Drugs and Treatment Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AbbVie Inc. Bipolar Disorder Drugs and Treatment Product Portfolio
6.1.5 AbbVie Inc. Recent Developments/Updates
6.2 Glaxo SmithKline (GSK)
6.2.1 Glaxo SmithKline (GSK) Company Information
6.2.2 Glaxo SmithKline (GSK) Description and Business Overview
6.2.3 Glaxo SmithKline (GSK) Bipolar Disorder Drugs and Treatment Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Glaxo SmithKline (GSK) Bipolar Disorder Drugs and Treatment Product Portfolio
6.2.5 Glaxo SmithKline (GSK) Recent Developments/Updates
6.3 Eli Lily and Company
6.3.1 Eli Lily and Company Company Information
6.3.2 Eli Lily and Company Description and Business Overview
6.3.3 Eli Lily and Company Bipolar Disorder Drugs and Treatment Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Eli Lily and Company Bipolar Disorder Drugs and Treatment Product Portfolio
6.3.5 Eli Lily and Company Recent Developments/Updates
6.4 Janssen Pharmaceuticals
6.4.1 Janssen Pharmaceuticals Company Information
6.4.2 Janssen Pharmaceuticals Description and Business Overview
6.4.3 Janssen Pharmaceuticals Bipolar Disorder Drugs and Treatment Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Janssen Pharmaceuticals Bipolar Disorder Drugs and Treatment Product Portfolio
6.4.5 Janssen Pharmaceuticals Recent Developments/Updates
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Company Information
6.5.2 Johnson & Johnson Description and Business Overview
6.5.3 Johnson & Johnson Bipolar Disorder Drugs and Treatment Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Johnson & Johnson Bipolar Disorder Drugs and Treatment Product Portfolio
6.5.5 Johnson & Johnson Recent Developments/Updates
6.6 Astellas Pharma Inc
6.6.1 Astellas Pharma Inc Company Information
6.6.2 Astellas Pharma Inc Description and Business Overview
6.6.3 Astellas Pharma Inc Bipolar Disorder Drugs and Treatment Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Astellas Pharma Inc Bipolar Disorder Drugs and Treatment Product Portfolio
6.6.5 Astellas Pharma Inc Recent Developments/Updates
6.7 Bristol Myers Squibb
6.7.1 Bristol Myers Squibb Company Information
6.7.2 Bristol Myers Squibb Description and Business Overview
6.7.3 Bristol Myers Squibb Bipolar Disorder Drugs and Treatment Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Bristol Myers Squibb Bipolar Disorder Drugs and Treatment Product Portfolio
6.7.5 Bristol Myers Squibb Recent Developments/Updates
6.8 Gedeon Richter PLC.
6.8.1 Gedeon Richter PLC. Company Information
6.8.2 Gedeon Richter PLC. Description and Business Overview
6.8.3 Gedeon Richter PLC. Bipolar Disorder Drugs and Treatment Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Gedeon Richter PLC. Bipolar Disorder Drugs and Treatment Product Portfolio
6.8.5 Gedeon Richter PLC. Recent Developments/Updates
6.9 H. Lundbeck A/S
6.9.1 H. Lundbeck A/S Company Information
6.9.2 H. Lundbeck A/S Description and Business Overview
6.9.3 H. Lundbeck A/S Bipolar Disorder Drugs and Treatment Sales, Revenue and Gross Margin (2020-2025)
6.9.4 H. Lundbeck A/S Bipolar Disorder Drugs and Treatment Product Portfolio
6.9.5 H. Lundbeck A/S Recent Developments/Updates
6.10 Pfizer Inc.
6.10.1 Pfizer Inc. Company Information
6.10.2 Pfizer Inc. Description and Business Overview
6.10.3 Pfizer Inc. Bipolar Disorder Drugs and Treatment Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Pfizer Inc. Bipolar Disorder Drugs and Treatment Product Portfolio
6.10.5 Pfizer Inc. Recent Developments/Updates
6.11 Novartis AG
6.11.1 Novartis AG Company Information
6.11.2 Novartis AG Description and Business Overview
6.11.3 Novartis AG Bipolar Disorder Drugs and Treatment Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Novartis AG Bipolar Disorder Drugs and Treatment Product Portfolio
6.11.5 Novartis AG Recent Developments/Updates
6.12 Otsuka Holdings Co. Ltd
6.12.1 Otsuka Holdings Co. Ltd Company Information
6.12.2 Otsuka Holdings Co. Ltd Description and Business Overview
6.12.3 Otsuka Holdings Co. Ltd Bipolar Disorder Drugs and Treatment Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Otsuka Holdings Co. Ltd Bipolar Disorder Drugs and Treatment Product Portfolio
6.12.5 Otsuka Holdings Co. Ltd Recent Developments/Updates
6.13 Validus Pharmaceuticals LLC.
6.13.1 Validus Pharmaceuticals LLC. Company Information
6.13.2 Validus Pharmaceuticals LLC. Description and Business Overview
6.13.3 Validus Pharmaceuticals LLC. Bipolar Disorder Drugs and Treatment Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Validus Pharmaceuticals LLC. Bipolar Disorder Drugs and Treatment Product Portfolio
6.13.5 Validus Pharmaceuticals LLC. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bipolar Disorder Drugs and Treatment Industry Chain Analysis
7.2 Bipolar Disorder Drugs and Treatment Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bipolar Disorder Drugs and Treatment Production Mode & Process Analysis
7.4 Bipolar Disorder Drugs and Treatment Sales and Marketing
7.4.1 Bipolar Disorder Drugs and Treatment Sales Channels
7.4.2 Bipolar Disorder Drugs and Treatment Distributors
7.5 Bipolar Disorder Drugs and Treatment Customer Analysis
8 Bipolar Disorder Drugs and Treatment Market Dynamics
8.1 Bipolar Disorder Drugs and Treatment Industry Trends
8.2 Bipolar Disorder Drugs and Treatment Market Drivers
8.3 Bipolar Disorder Drugs and Treatment Market Challenges
8.4 Bipolar Disorder Drugs and Treatment Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
AbbVie
Glaxo SmithKline (GSK)
Eli Lily And Company
Janssen Pharmaceuticals
Johnson & Johnson
Astellas Pharma Inc
Bristol–Myers Squibb
Gedeon Richter Plc
H Lundbeck A S
Pfizer Inc
Novartis
Otsuka Holdings Co Ltd
Validus Pharmaceuticals LLC
List of Tables
 Table 1. Global Bipolar Disorder Drugs and Treatment Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Bipolar Disorder Drugs and Treatment Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Bipolar Disorder Drugs and Treatment Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Bipolar Disorder Drugs and Treatment Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Bipolar Disorder Drugs and Treatment Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Bipolar Disorder Drugs and Treatment Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Bipolar Disorder Drugs and Treatment Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Bipolar Disorder Drugs and Treatment Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Bipolar Disorder Drugs and Treatment, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Bipolar Disorder Drugs and Treatment, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Bipolar Disorder Drugs and Treatment, Product Type & Application
 Table 12. Global Key Manufacturers of Bipolar Disorder Drugs and Treatment, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Bipolar Disorder Drugs and Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bipolar Disorder Drugs and Treatment as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Bipolar Disorder Drugs and Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Bipolar Disorder Drugs and Treatment Sales by Region (2020-2025) & (K Units)
 Table 18. Global Bipolar Disorder Drugs and Treatment Sales Market Share by Region (2020-2025)
 Table 19. Global Bipolar Disorder Drugs and Treatment Sales by Region (2026-2031) & (K Units)
 Table 20. Global Bipolar Disorder Drugs and Treatment Sales Market Share by Region (2026-2031)
 Table 21. Global Bipolar Disorder Drugs and Treatment Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Bipolar Disorder Drugs and Treatment Revenue Market Share by Region (2020-2025)
 Table 23. Global Bipolar Disorder Drugs and Treatment Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Bipolar Disorder Drugs and Treatment Revenue Market Share by Region (2026-2031)
 Table 25. North America Bipolar Disorder Drugs and Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Bipolar Disorder Drugs and Treatment Sales by Country (2020-2025) & (K Units)
 Table 27. North America Bipolar Disorder Drugs and Treatment Sales by Country (2026-2031) & (K Units)
 Table 28. North America Bipolar Disorder Drugs and Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Bipolar Disorder Drugs and Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Bipolar Disorder Drugs and Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Bipolar Disorder Drugs and Treatment Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Bipolar Disorder Drugs and Treatment Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Bipolar Disorder Drugs and Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Bipolar Disorder Drugs and Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Bipolar Disorder Drugs and Treatment Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Bipolar Disorder Drugs and Treatment Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Bipolar Disorder Drugs and Treatment Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Bipolar Disorder Drugs and Treatment Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Bipolar Disorder Drugs and Treatment Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Bipolar Disorder Drugs and Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Bipolar Disorder Drugs and Treatment Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Bipolar Disorder Drugs and Treatment Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Bipolar Disorder Drugs and Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Bipolar Disorder Drugs and Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Bipolar Disorder Drugs and Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Bipolar Disorder Drugs and Treatment Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Bipolar Disorder Drugs and Treatment Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Bipolar Disorder Drugs and Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Bipolar Disorder Drugs and Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Bipolar Disorder Drugs and Treatment Sales (K Units) by Type (2020-2025)
 Table 51. Global Bipolar Disorder Drugs and Treatment Sales (K Units) by Type (2026-2031)
 Table 52. Global Bipolar Disorder Drugs and Treatment Sales Market Share by Type (2020-2025)
 Table 53. Global Bipolar Disorder Drugs and Treatment Sales Market Share by Type (2026-2031)
 Table 54. Global Bipolar Disorder Drugs and Treatment Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Bipolar Disorder Drugs and Treatment Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Bipolar Disorder Drugs and Treatment Revenue Market Share by Type (2020-2025)
 Table 57. Global Bipolar Disorder Drugs and Treatment Revenue Market Share by Type (2026-2031)
 Table 58. Global Bipolar Disorder Drugs and Treatment Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Bipolar Disorder Drugs and Treatment Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Bipolar Disorder Drugs and Treatment Sales (K Units) by Application (2020-2025)
 Table 61. Global Bipolar Disorder Drugs and Treatment Sales (K Units) by Application (2026-2031)
 Table 62. Global Bipolar Disorder Drugs and Treatment Sales Market Share by Application (2020-2025)
 Table 63. Global Bipolar Disorder Drugs and Treatment Sales Market Share by Application (2026-2031)
 Table 64. Global Bipolar Disorder Drugs and Treatment Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Bipolar Disorder Drugs and Treatment Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Bipolar Disorder Drugs and Treatment Revenue Market Share by Application (2020-2025)
 Table 67. Global Bipolar Disorder Drugs and Treatment Revenue Market Share by Application (2026-2031)
 Table 68. Global Bipolar Disorder Drugs and Treatment Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Bipolar Disorder Drugs and Treatment Price (US$/Unit) by Application (2026-2031)
 Table 70. AbbVie Inc. Company Information
 Table 71. AbbVie Inc. Description and Business Overview
 Table 72. AbbVie Inc. Bipolar Disorder Drugs and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. AbbVie Inc. Bipolar Disorder Drugs and Treatment Product
 Table 74. AbbVie Inc. Recent Developments/Updates
 Table 75. Glaxo SmithKline (GSK) Company Information
 Table 76. Glaxo SmithKline (GSK) Description and Business Overview
 Table 77. Glaxo SmithKline (GSK) Bipolar Disorder Drugs and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Glaxo SmithKline (GSK) Bipolar Disorder Drugs and Treatment Product
 Table 79. Glaxo SmithKline (GSK) Recent Developments/Updates
 Table 80. Eli Lily and Company Company Information
 Table 81. Eli Lily and Company Description and Business Overview
 Table 82. Eli Lily and Company Bipolar Disorder Drugs and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Eli Lily and Company Bipolar Disorder Drugs and Treatment Product
 Table 84. Eli Lily and Company Recent Developments/Updates
 Table 85. Janssen Pharmaceuticals Company Information
 Table 86. Janssen Pharmaceuticals Description and Business Overview
 Table 87. Janssen Pharmaceuticals Bipolar Disorder Drugs and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Janssen Pharmaceuticals Bipolar Disorder Drugs and Treatment Product
 Table 89. Janssen Pharmaceuticals Recent Developments/Updates
 Table 90. Johnson & Johnson Company Information
 Table 91. Johnson & Johnson Description and Business Overview
 Table 92. Johnson & Johnson Bipolar Disorder Drugs and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Johnson & Johnson Bipolar Disorder Drugs and Treatment Product
 Table 94. Johnson & Johnson Recent Developments/Updates
 Table 95. Astellas Pharma Inc Company Information
 Table 96. Astellas Pharma Inc Description and Business Overview
 Table 97. Astellas Pharma Inc Bipolar Disorder Drugs and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Astellas Pharma Inc Bipolar Disorder Drugs and Treatment Product
 Table 99. Astellas Pharma Inc Recent Developments/Updates
 Table 100. Bristol Myers Squibb Company Information
 Table 101. Bristol Myers Squibb Description and Business Overview
 Table 102. Bristol Myers Squibb Bipolar Disorder Drugs and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Bristol Myers Squibb Bipolar Disorder Drugs and Treatment Product
 Table 104. Bristol Myers Squibb Recent Developments/Updates
 Table 105. Gedeon Richter PLC. Company Information
 Table 106. Gedeon Richter PLC. Description and Business Overview
 Table 107. Gedeon Richter PLC. Bipolar Disorder Drugs and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Gedeon Richter PLC. Bipolar Disorder Drugs and Treatment Product
 Table 109. Gedeon Richter PLC. Recent Developments/Updates
 Table 110. H. Lundbeck A/S Company Information
 Table 111. H. Lundbeck A/S Description and Business Overview
 Table 112. H. Lundbeck A/S Bipolar Disorder Drugs and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. H. Lundbeck A/S Bipolar Disorder Drugs and Treatment Product
 Table 114. H. Lundbeck A/S Recent Developments/Updates
 Table 115. Pfizer Inc. Company Information
 Table 116. Pfizer Inc. Description and Business Overview
 Table 117. Pfizer Inc. Bipolar Disorder Drugs and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Pfizer Inc. Bipolar Disorder Drugs and Treatment Product
 Table 119. Pfizer Inc. Recent Developments/Updates
 Table 120. Novartis AG Company Information
 Table 121. Novartis AG Description and Business Overview
 Table 122. Novartis AG Bipolar Disorder Drugs and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Novartis AG Bipolar Disorder Drugs and Treatment Product
 Table 124. Novartis AG Recent Developments/Updates
 Table 125. Otsuka Holdings Co. Ltd Company Information
 Table 126. Otsuka Holdings Co. Ltd Description and Business Overview
 Table 127. Otsuka Holdings Co. Ltd Bipolar Disorder Drugs and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Otsuka Holdings Co. Ltd Bipolar Disorder Drugs and Treatment Product
 Table 129. Otsuka Holdings Co. Ltd Recent Developments/Updates
 Table 130. Validus Pharmaceuticals LLC. Company Information
 Table 131. Validus Pharmaceuticals LLC. Description and Business Overview
 Table 132. Validus Pharmaceuticals LLC. Bipolar Disorder Drugs and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Validus Pharmaceuticals LLC. Bipolar Disorder Drugs and Treatment Product
 Table 134. Validus Pharmaceuticals LLC. Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Bipolar Disorder Drugs and Treatment Distributors List
 Table 138. Bipolar Disorder Drugs and Treatment Customers List
 Table 139. Bipolar Disorder Drugs and Treatment Market Trends
 Table 140. Bipolar Disorder Drugs and Treatment Market Drivers
 Table 141. Bipolar Disorder Drugs and Treatment Market Challenges
 Table 142. Bipolar Disorder Drugs and Treatment Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Bipolar Disorder Drugs and Treatment
 Figure 2. Global Bipolar Disorder Drugs and Treatment Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Bipolar Disorder Drugs and Treatment Market Share by Type: 2024 & 2031
 Figure 4. Mood Stabilizers Product Picture
 Figure 5. Anticonvulsants Product Picture
 Figure 6. Antipsychotic Drugs Product Picture
 Figure 7. Antidepressant Drugs Product Picture
 Figure 8. Anti-Anxiety Drugs Product Picture
 Figure 9. Global Bipolar Disorder Drugs and Treatment Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Bipolar Disorder Drugs and Treatment Market Share by Application: 2024 & 2031
 Figure 11. Hospital
 Figure 12. Clinic
 Figure 13. Global Bipolar Disorder Drugs and Treatment Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Bipolar Disorder Drugs and Treatment Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Bipolar Disorder Drugs and Treatment Sales (2020-2031) & (K Units)
 Figure 16. Global Bipolar Disorder Drugs and Treatment Average Price (US$/Unit) & (2020-2031)
 Figure 17. Bipolar Disorder Drugs and Treatment Report Years Considered
 Figure 18. Bipolar Disorder Drugs and Treatment Sales Share by Manufacturers in 2024
 Figure 19. Global Bipolar Disorder Drugs and Treatment Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Bipolar Disorder Drugs and Treatment Players: Market Share by Revenue in Bipolar Disorder Drugs and Treatment in 2024
 Figure 21. Bipolar Disorder Drugs and Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Bipolar Disorder Drugs and Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Bipolar Disorder Drugs and Treatment Sales Market Share by Country (2020-2031)
 Figure 24. North America Bipolar Disorder Drugs and Treatment Revenue Market Share by Country (2020-2031)
 Figure 25. U.S. Bipolar Disorder Drugs and Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Bipolar Disorder Drugs and Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Bipolar Disorder Drugs and Treatment Sales Market Share by Country (2020-2031)
 Figure 28. Europe Bipolar Disorder Drugs and Treatment Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Bipolar Disorder Drugs and Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Bipolar Disorder Drugs and Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Bipolar Disorder Drugs and Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Bipolar Disorder Drugs and Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Bipolar Disorder Drugs and Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Bipolar Disorder Drugs and Treatment Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Bipolar Disorder Drugs and Treatment Revenue Market Share by Region (2020-2031)
 Figure 36. China Bipolar Disorder Drugs and Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Bipolar Disorder Drugs and Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Bipolar Disorder Drugs and Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Bipolar Disorder Drugs and Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Bipolar Disorder Drugs and Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Taiwan Bipolar Disorder Drugs and Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Bipolar Disorder Drugs and Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Bipolar Disorder Drugs and Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Bipolar Disorder Drugs and Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Philippines Bipolar Disorder Drugs and Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Bipolar Disorder Drugs and Treatment Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Bipolar Disorder Drugs and Treatment Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Bipolar Disorder Drugs and Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Bipolar Disorder Drugs and Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Bipolar Disorder Drugs and Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Bipolar Disorder Drugs and Treatment Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Bipolar Disorder Drugs and Treatment Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Bipolar Disorder Drugs and Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Bipolar Disorder Drugs and Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. U.A.E Bipolar Disorder Drugs and Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Bipolar Disorder Drugs and Treatment by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Bipolar Disorder Drugs and Treatment by Type (2020-2031)
 Figure 58. Global Bipolar Disorder Drugs and Treatment Price (US$/Unit) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Bipolar Disorder Drugs and Treatment by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Bipolar Disorder Drugs and Treatment by Application (2020-2031)
 Figure 61. Global Bipolar Disorder Drugs and Treatment Price (US$/Unit) by Application (2020-2031)
 Figure 62. Bipolar Disorder Drugs and Treatment Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Bipolar Disorder Drug Treatment Market Research Report 2024
Global Bipolar Disorder Treatment Market Research Report 2024
Bipolar Disorder Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Mood Stabilizers Market Research Report 2024
Global Bipolar Disorder Therapeutics Drugs Market Insights Forecast to 2030
Mood Disorder Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Bipolar Disorders and Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Medical Lithium Carbonate Market Research Report 2024
Bipolar Disorder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Mental Health Medications Market Research Report 2025
Mental Disorder Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Electroconvulsive Therapy Devices Market Research Report 2024
Depression Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drugs for Treating Mental Disorders Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anti depressant Drugs Market
Global Epilepsy Treatment Drug Market Research Report 2024
Lithium Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Major Depressive Disorder Drug Market Research Report 2025
Global Psychiatric and Nervous Drugs Market Research Report 2025
Global Psychiatric Medication Therapies Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions